CNBG’s monoclonal antibody against Omicron variants approved for clinical trials
A monoclonal antibody against SARS-CoV-2 has been approved by China’s medical authorities for clinical trials, which is of great significance…
A monoclonal antibody against SARS-CoV-2 has been approved by China’s medical authorities for clinical trials, which is of great significance…